findmyKOL
Clinical trialNCT00133952CompletedPhase 3Interventional

Effect of Ruboxistaurin on Clinically Significant Macular Edema

SponsorChromaderm, Inc.Enrollment309Diabetic Macular Edema
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Halifax, Nova Scotia, Canada

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    London, Ontario, Canada

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Mississauga, Ontario, Canada

Denmark
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Aarhus, Denmark

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Glostrup Municipality, Denmark

Germany
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Bonn, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Leipzig, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Münster, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Ulm, Germany

Lithuania
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Kaunas, Lithuania

Mexico
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Mexico City, Mexico

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Monterrey, Mexico

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    San Luis Potosí City, Mexico

Portugal
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Coimbra, Portugal

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Lisbon, Portugal

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Porto, Portugal

Romania
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Bucharest, Romania

Spain
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Alicante, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Barcelona, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Valladolid, Spain

United Kingdom
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    London, Greater London, United Kingdom

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    London, United Kingdom

United States
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Phoenix, Arizona, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Artesia, California, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Newark, Delaware, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Jacksonville, Florida, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Augusta, Georgia, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Indianapolis, Indiana, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Baltimore, Maryland, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Boston, Massachusetts, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Grand Rapids, Michigan, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Portsmouth, New Hampshire, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Slingerlands, New York, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Asheville, North Carolina, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Lakewood, Ohio, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Kingston, Pennsylvania, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Pittsburgh, Pennsylvania, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    West Mifflin, Pennsylvania, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Dallas, Texas, United States

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Houston, Texas, United States

1 more site on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2005
Primary completion
31 Jul 2011
Completion
31 Jul 2011
Last update posted
6 Oct 2016
Registered enrollment
309
Registry id
NCT00133952

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.